Streptococcus
• Gram positive • Non motile
• Ovoid to spherical in shape
facultative anaerobic, Catalase negative (staphylococci are catalase positive).
Ferment sugar even in the presence of oxygen
• Require nutrient rich environments
• Identified by their growth patterns on blood agar
Summary of differences between
staphylococci and streptococci
• Gram stain and morphology – Both Gram +
– Staphylococci: bunched cocci
– Streptococci: chained cocci (S. pneumoniae form diplococcus) • Enzyme tests
– Staphylococci: catalase + – Streptococci: catalase -• Growth
Streptococcus
and
Enterococcus
: Cell Wall
Structure
• Thick peptidoglycan layer • Teichoic acid
• C=carbohydrate layer present except
in viridans group
– C carbohydrates used in
Lancefield grouping of
Streptococcus spp. (EXCEPT S. pneumoniae and S. viridans)
– Groups A, B, C, D, etc.
• Capsule in S. pneumoniae and in
Clinically Significant Streptococci: Streptococcus
pyogenes or Group A Beta-Hemolytic Streptococci
• Bacterial structure
– Fimbrae: attachment and
adherence
– M protein: major virulence
factor: resistance to phagocytosis
– Hyaluronic acid capsule:
• Streptococci are subdivided into groups by
antibodies that recognize surface antigens
• The most important groupable streptococci are
A, B and D.
• Among the groupable streptococci, infectious
disease (particularly pharyngitis) is caused by
group A (Pyogenic)
• Streptococcus pneumoniae (a major cause of
human pneumonia)
• Streptococcus mutans and other so-called
viridans streptococci (among the causes of
dental caries) do not possess group antigens.
• The hemolysis reaction is important in grouping
streptococci.
• The hemolysis reaction along with one
physiologic characteristic is sufficient for a
• Group A and group B streptococci are
beta hemolytic
• Group D are usually gamma or non
• Streptococcus pneumoniae and viridans
streptococci are alpha hemolytic ("green")
Streptococcus pyogenes or Group A Streptococci: Virulence Factors
• Hemolysins
– Streptolysin O, can be detected by ASO test – Streptolysin S (O2 stable)
• Erythrogenic toxin • Enzymes
– Streptokinase – DNases
S. pyogenes
(Group A) traditionally causes a suppurative, non-invasive pharyngitis.Streptococcus pyogenes (Group A) Streptococcal Infections
• Acute bacterial pharyngitis
– Sore throat – Malaise
– Fever/headache
• Scarlet fever
• Pyodermal infections – Impetigo
– Erysipelas
• Cellulitis Erysipelas due to
Scarlet Fever
• Rash is an inflammatory reaction to the
erythrogenic toxin
• The toxin produced by a gene
“
Flesh-Eating Bacteria
”
Cellulitis
– Severe form of infection that is life-threatening
Invasive Group A Streptococcal Infections
• Streptococcal toxic shock syndrome
– Multi-organ system failure similar to
staphylococcal toxic shock
– Initial infection may have been pharyngitis,
Group A streptococcal infections affect all ages with
peak incidence at 5-15 years of age.
Ther serious complications including: 1- Rheumatic fever
2- Invasive bacteremia)
Affect primarily those with some underlying
defect in their immune system including:
infants, elderly people
and those immunocompromised).
Rheumatic fever
An inflammatory disease affecting primarily the
heart and joints.
The mechanism of chronic immunopathology
Early termination of throat infections with
penicillin therapy decreases the incidence of the
Acute glomerulonephritis
Bacteremia and toxic-shock
.
The newly described invasive (and sometimes
fatal) forms of the disease with a toxic shock-like
disease (including rash, fever and shifting of Fluid from the bloodstream to peripheral
tissues and/or with resulting edema) necrotizing myositis and fasciitis.
Production of pyrogenic toxins (A, B and C) are
Laboratory diagnosis
1. Direct detection - the antigen is extracted from a throat swab.
a. The antigen extract will then bind with antibody
specific to the group A streptococcal carbohydrate. b. This has classically involved agglutination of
antibody coated beads.
2. Lancefield grouping of isolated beta hemolytic colonies.
Colonies are beta hemolytic and their growth is
inhibited by bacitracin (presumptive diagnosis).
Patient serum shows antibodies to streptolysin
O (ASO titer test), or other streptococcal antigens The strains of the bacteria possesses O and S
Bacitracin
• A filter paper disc impregnated with the
antibiotic Bacitracin is placed on a blood agar plate containing bacteria
• If there is a zone of inhibition around the
disk it is indicative of a Group A streptococci
Biochemical Identification
• Susceptibility tests
– Bacitracin (0.04 units) or
“A” disk or “Taxo A” disk
• Identifies Group A
streptococci
Biochemical Identification
• Susceptibility test
– Trimethoprim sulfamethoxazole
(SXT)
• STX Inhibits other
beta-hemolytic streptococcal groups
but not A and B
Group A streptococcus growing in the presence of SXT
• Group A
Resistance to STX
Biochemical Identification
• PYR hydrolysis
– Substrate L-pyrrolidonyl-
b-napthlyamide (PYR) is hydrolyzed by Group A Streptococci and
Enterococcus sp.
PYR test for Group A
Group B streptococcus
(
S. agalactiae
)
These organisms cause neonatal meningitis and
septicemia after transmission from the
Group B Streptococcus
• Colony morphology
– Grayish-white, mucoid,
creamy, narrow zone of b -hemolysis
• Presumptive Identification tests
Biochemical Identification
• Christie-Atkins,Munch-Petersen (CAMP) test
– Detects the production of
enhanced hemolysis that occurs when b-lysin and the hemolysins of Group B
streptococci come in contact
Group B streptococci showing the classical “arrow-shaped
Group B streptococcus
The organism can be identified on the basis of:
1. Beta hemolysis
2. hydrolysis of hippurate
3. CAMP reaction
• CAMP is an abbreviation for the names of the 4
individuals who originally described the test.
Group B streptococci produce a factor that increases
Identification Schema
Group D streptococcus
Group D streptococci are divided into:
• those that will grow in 6.5% saline (enterococci)
• and those that will not (non-enterococci)
Streptococcus Group D
Group D = S. bovis
• Members of the gut flora (Natural habitat is large intestine)
• Associated infections
– Bacteremia
– Urinary tract infections – Wound infections
Biochemical Identification
• Bile Esculin hydrolysis– Ability to grow in 40% bile and
hydrolyze Esculin are features of streptococci that possess Group D antigen (we use BE slants in lab instead of plates) • Growth in 6.5% NaCl broth
– Differentiates Group D
streptococci from enterococci
• Enterococci are often resistant to penicillin.
• Enterococci are distantly related to other
streptococci and have been moved into the genus
Enterococcus the most commonly isolated is ;
E. (S.) faecalis.
• Enterococci are found in the gut flora.
• A significant cause of urinary tract infections
(much less common than E. coli)
• A source of opportunistic infections including:
intra-abdominal
septicemia
endocarditis
Bacterial Pneumonia
Streptococcus pneumoniae
• Often secondary
infection following influenza virus
Microscopic morphology
Laboratory Diagnosis:
Streptococcus pneumoniae
• Colony morphology – Smooth, glistening,
wet-looking, mucoid
– a-Hemolytic – CO2enhances
growth
– As colony ages,
Laboratory Diagnosis:
Streptococcus pneumoniae
• Identification– Catalase negative –
Optochin-susceptibility-test– (susceptible)
– Bile-solubility-test–
Biochemical Identification
for streptococcus pneumoniae
• Susceptibility test
– Optochin “P” disk or “Taxo P” disk
• Differentiates S. pneumoniae from other
alpha-hemolytic streptococci (Viridans group) • Bile solubility test
– S pneumoniae lyses in a suspension of sodium deoxycholate while
Streptococcus pneumoniae
• Streptococcus pneumoniae is responsible for
pneumonia, bacteremia, otitis media, meningitis, sinusitis, peritonitis and arthritis
Resistance of Streptococcus pneumoniae to penicillin and other beta-lactams is increasing worldwide.
Viridans streptococci
• A diverse group of species commonly found orally
(including S. mutans).
• Cause endocarditis after release into the
bloodstream from tooth extraction.
• They are also involved in dental caries.
• Are ailpha hemolytic and negative for other tests
described above.
Treatment
Group A: treatment start with penicillin,
Erythromycin or another macrolide can be used in patients who are allergic to penicillin
Group B treatment: Penicillin or ampicillin + one of aminoglycosides
Clindamycin, and Vamcomycin are treatments of choice
Streptococcus pneumonia treatment with penicillin.
penicillin-resistant strains may also be resistant to erythromycin, macrolides, and clindamycin and the quinolones.
Vaccination
• Prevention– Vaccine possible – Target against M
• Is there a vaccine that can prevent infections?
• Yes. There are two different vaccines – one primarily for adults and one for children. The vaccine for adults has been available for many years and is called the
pneumococcal polysaccharide vaccine (Pneumovax or Pneu-Imune). It is effective in preventing the most serious complications of pneumococcal infection. The pediatric vaccine is called the pneumococal conjugate vaccine (Prevnar) and is only for use in children under 5 years of age.
• Possible problems